Methylene Blue Capsules Price Comparison — Prices & Recorded COA Details

Compare Methylene Blue capsule prices, capsule count, mg per capsule, cost per capsule, and recorded COA metadata. Inspect actual batch reports independently.

Compare Methylene Blue Capsules purchase prices, nominal quantities, discount codes and recorded COA fields. Availability flags, purity values and dates are metadata, not independent verification; inspect the actual batch report.

About Methylene Blue

Compound context: FDA-approvedAlso known as: Methylthioninium chloride · MB

Methylene Blue is compared here in capsule format. Capsule count, strength per capsule, and total milligrams per bottle describe the listed product; they do not establish a dosing protocol.

What to check before you buy Methylene Blue:

  • Confirm capsule count and milligrams per capsule on the finished product label.
  • Check that the actual report identifies the finished capsule product and matches its batch and strength.
  • Compare bottle price separately from price per capsule and price per milligram. Missing quantities cannot support normalized comparisons.

Research context — not capsule instructions or evidence of equivalent dosing: The methemoglobinemia and ifosfamide-encephalopathy indications are supported by decades of clinical use and case-series literature.[1][2] Off-label and investigational research areas include neuroprotection, Alzheimer's disease (the TauRx LMTM/leuco-methylthioninium program, a related but distinct molecule, advanced through Phase 3 in Alzheimer's disease but did not achieve regulatory approval),[6] septic shock vasoplegia, malaria adjunct therapy, and cognitive enhancement. The cognitive-enhancement and longevity uses are essentially pre-clinical and small-Phase-2 — supported by tissue-culture and rodent data but not by any large-scale human efficacy trial.[3][4]

Regulatory: Compound-level context, not approval of the capsule listings: FDA-approved for drug-induced methemoglobinemia and ifosfamide-induced encephalopathy. Off-label and investigational use for neuroprotection, cognition, and mitochondrial support is widespread but not approved. Important MAO-A interaction with serotonergic drugs.

Read the full mechanism & research breakdown

Methylene Blue: Mechanisms, Half-Life & Research Data

Compound research context for Methylene Blue, not capsule dosing guidance. Studies of other formulations do not establish equivalence to these listings. All citations resolve to the sources list at the bottom of this page.

How it works

Research on the compound and other formulations does not establish the properties or dose of the capsules listed here. Methylene blue is a phenothiazine-derived heterocyclic compound that exists in two reversibly interconverting redox states: the oxidised (blue) methylene blue form and the reduced (colourless) leucomethylene blue form. This redox cycling is the basis for essentially all of its pharmacology.[3][4] In the mitochondrial electron-transport chain, methylene blue can accept electrons from NADH and donate them to cytochrome c, effectively bypassing complex I and partial dysfunction at complexes I/III — the published basis for the mitochondrial-support and neuroprotective effects studied in pre-clinical models.[7] In red blood cells, NADPH-dependent reduction of methylene blue to leucomethylene blue (via methemoglobin reductase) yields a strong reducing agent that converts methemoglobin back to functional ferrous hemoglobin — the basis for the methemoglobinemia indication.[1] Methylene blue is also a potent reversible MAO-A inhibitor at moderate-to-high systemic concentrations, creating a clinically important serotonin-syndrome risk in patients taking SSRIs, SNRIs, MAOIs, or other serotonergic drugs.[5] The MAO-A inhibition contributes to a paradoxical pharmacology: at low doses methylene blue acts primarily as a mitochondrial electron shuttle; at high doses it becomes a more conventional CNS-active small molecule.

Active research areas

  • Methemoglobinemia (FDA-approved)
    The historical and primary FDA-approved indication. Intravenous methylene blue rapidly reduces methemoglobin in drug-induced and chemical-induced methemoglobinemia, with the indication well-established by case series and approved labelling.[1]
  • Ifosfamide-induced encephalopathy (approved indication)
    Methylene blue is established as a treatment and prophylaxis for ifosfamide-induced encephalopathy in oncology, supported by case-series literature and approved labelling.[2]
  • Alzheimer's disease (TauRx LMTM program, Phase 3 mixed result)
    A leuco-methylthioninium derivative (LMTM, related but distinct from methylene blue) advanced through Phase 3 trials in mild-moderate Alzheimer's disease. The trials produced complex results — the primary endpoints were not met overall, though pre-specified subgroup analyses suggested possible benefit — and the molecule has not received regulatory approval as an Alzheimer's therapy.[6]
  • Septic-shock vasoplegia (off-label, intensive care)
    Methylene blue is used off-label in intensive-care settings for catecholamine-resistant vasoplegic shock, leveraging its inhibition of nitric-oxide-synthase/guanylyl-cyclase signalling to raise vascular tone.[8] The evidence base is case-series and small-trial, not large randomised data.
  • Cognitive enhancement and neuroprotection (pre-clinical / small Phase 2)
    Pre-clinical and small Phase 2 work in cognitive aging, traumatic brain injury, and Parkinson's disease has explored low-dose methylene blue as a mitochondrial-support and neuroprotective intervention, with mixed and exploratory results that do not support routine off-label cognitive use.[4][7]
Sources & references (9)

Peer-reviewed literature, FDA documents, and trial registrations cited above. Vendor pricing, COA data, and live calculator statistics shown elsewhere on this page are sourced from the WPA database independently of this list.

  1. [1]FDA Label — Provayblue (methylene blue injection) for acquired methemoglobinemia, FDA approval letter and prescribing information. link
  2. [2]Pelgrims J et al. Methylene blue in the treatment and prevention of ifosfamide-induced encephalopathy: report of 12 cases and a review of the literature. Br J Cancer 2000;82:291–294. · PMID: 10646879 link
  3. [3]Atamna H et al. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J 2008;22:703–712. · PMID: 17928358 link
  4. [4]Tucker D et al. From mitochondrial function to neuroprotection — an emerging role for methylene blue. Mol Neurobiol 2018;55:5137–5153. · PMID: 28840449 link
  5. [5]FDA Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications, July 2011. link
  6. [6]Gauthier S et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial (TauRx LMTM). Lancet 2016;388:2873–2884. · PMID: 27863809 link
  7. [7]Rojas JC et al. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol 2012;96:32–45. · PMID: 22067440 link
  8. [8]Ginimuge PR, Jyothi SD. Methylene blue: revisited. J Anaesthesiol Clin Pharmacol 2010;26:517–520 — review of clinical pharmacology and safety. · PMID: 21547182 link
  9. [9]Community report — r/Nootropics methylene blue discussion threads (subreddit), accessed May 2026. link

What Methylene Blue Capsules Costs Right Now

WPA currently tracks Methylene Blue Capsules from 2 distinct vendors. In-stock Methylene Blue Capsules bottles run from $15.29 to $67.15 — a 4.4x spread for the same compound. Swiss Chems holds the lowest sticker price at $15.29. Normalized to milligrams, Methylene Blue Capsules costs $0.025/mg to $0.034/mg on this page. The best per-milligram value is the listed 600 mg purchase quantity from Swiss Chems.

Methylene Blue Capsules is stocked in 2 sizes: 2000 mg per package; 600 mg per package. Because bottles of different strengths rarely scale linearly in price, the per-milligram column is the only fair way to rank them.

Ranked by true cost per milligram, the Methylene Blue Capsules listings WPA tracks are: Swiss Chems — 600mg at $15.29 ($0.025/mg); Southern Aminos — 2000mg at $67.15 ($0.034/mg).

Methylene Blue Capsules COA Coverage Across Tracked Vendors

2 of the 2 tracked Methylene Blue Capsules listings (100%) are marked as having COA availability in WPA's listing data; this marker is not independent verification. The latest COA date recorded in WPA's listing data is 2/26.

To assess a COA, inspect the actual report for the independent lab, test date, and a batch and bottle size matching the Methylene Blue Capsules offer. WPA's listing fields do not establish that a report was independently verified.

Methylene Blue Capsules Discount Codes

2 of the 2 tracked Methylene Blue Capsules listings carry a WPA researcher discount code. The largest live discount is 15% off. Every price and per-milligram figure on this page is the post-discount number, so you are never comparing a discounted listing against an undiscounted one. Codes change and some exclude sale items or carry order minimums.

About Methylene Blue

Methylene Blue is compared here in capsule format. Capsule count, strength per capsule, and total milligrams per bottle describe the listed product; they do not establish a dosing protocol.

Methylene Blue is tracked under the Anti-Aging Peptides category on WPA. Compound-level context, not approval of the capsule listings: FDA-approved for drug-induced methemoglobinemia and ifosfamide-induced encephalopathy.

How to Read the Methylene Blue Capsules Comparison

  • Price per milligram — Every Methylene Blue Capsules listing is normalized to $0.025/mg-style unit pricing, so a small cheap bottle cannot hide a worse real cost than a larger one.
  • COA metadata and purity — 2 Methylene Blue Capsules listings are marked for COA availability, and 0 have a recorded purity value. These fields do not independently verify a report.
  • Bottles sizes — The Methylene Blue Capsules comparison includes 600mg and 2000mg listed purchase quantities. Check package composition separately.
  • Stock status — Live in-stock state for each Methylene Blue Capsules listing, refreshed on a recurring basis.

Reading Methylene Blue Capsule Listings

Capsule listings are ranked on total Methylene Blue per bottle — capsule count multiplied by milligrams per capsule — rather than on bottle price, because a cheaper bottle with fewer or weaker capsules routinely costs more per milligram. A capsule COA should test the finished capsule rather than the raw powder, and it should cover the exact capsule strength on sale.

Oral capsule formats differ from injectable vials in route of administration and bioavailability, so a Methylene Blue protocol written for one format does not transfer to the other. Confirm the vendor's COA covers the capsule product specifically.

Frequently Asked Questions: Methylene Blue Capsules

How are Methylene Blue capsule prices compared?

Bottle price, capsule count, and milligrams per capsule are separate listing fields. Total milligrams per bottle equals capsule count × milligrams per capsule; price per milligram divides the bottle price by that total. Price per capsule divides the bottle price by the capsule count. A missing quantity leaves the corresponding normalized price unavailable.

Are Methylene Blue capsules supplied as powder for reconstitution?

These listings are capsules, not vials for reconstitution. Check the finished capsule label, capsule count, strength, and matching batch report. Vial preparation instructions do not apply to capsule listings.

Can calculator entries establish a Methylene Blue capsule protocol?

No. WPA calculator entries are compound-wide inputs, not confirmed administration or capsule-specific usage. They do not establish a capsule dose, schedule, bottle duration, or monthly protocol cost. This page compares catalog prices without seeding a capsule monthly planner.

Can Methylene Blue capsule and injectable doses be converted?

No route-equivalent dose can be inferred from these listings. Absorption depends on the compound and formulation; a generic absorption percentage or multiplier cannot establish capsule dosing. Cited studies of other formulations are research context, not instructions for the capsules offered here.